Thromb Haemost 2009; 102(04): 790-792
DOI: 10.1160/TH09-02-0135
Letters to the Editor
Schattauer GmbH

Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia

Shu He
1   Department of Clinical Sciences, Danderyds Hospital Karolinska Institutet, Stockholm, Sweden
2   Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
,
Mirella Ezban
3   Biopharmaceuticals Research Unit, Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark
,
Niklas Bark
2   Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
4   Department of linical Neuroscience, Karolinska Institutet, Stockholm, Sweden;
,
Egon Persson
3   Biopharmaceuticals Research Unit, Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark
,
Ulla Hedner
3   Biopharmaceuticals Research Unit, Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark
5   University of Lund, Sweden
› Author Affiliations
Grants/financial support: This study was partly funded by a research grant from Novo Nordisk A/S
Further Information

Publication History

Received: 03 July 2009

Accepted after major revision: 07 July 2009

Publication Date:
24 November 2017 (online)

Zoom Image